Literature DB >> 15546798

Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.

Xiaoping Qing1, Chaim Putterman.   

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a complex pathogenesis involving multiple genetic and environmental contributions. DNA microarray technology has recently been applied to unravel some of this complexity through genomewide profiling. Early studies using microarray analysis of peripheral blood mononuclear cells (PBMCs) from SLE patients revealed dysregulation of inflammatory cytokines, chemokines, and immune response-related genes, as well as genes involved in apoptosis, signal transduction, and the cell cycle. More recently, using arrays containing many more genes, 4 independent research groups have found that interferon (IFN)-regulated genes are highly overexpressed in the peripheral blood and kidney glomeruli of SLE patients, supporting a crucial role for interferon in SLE. Future studies focusing on target tissues or organs in lupus, including the kidney, may further contribute to our understanding of lupus pathogenesis while providing new targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546798     DOI: 10.1016/j.autrev.2004.07.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  12 in total

1.  Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion.

Authors:  Mar Naranjo-Gómez; Nuria Climent; Joan Cos; Harold Oliva; Margarita Bofill; José M Gatell; Teresa Gallart; Ricardo Pujol-Borrell; Francesc E Borràs
Journal:  Immunology       Date:  2006-08-24       Impact factor: 7.397

2.  Gene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody production.

Authors:  Geeta Rai; Satyajit Ray; Jacqueline Milton; Jun Yang; Ping Ren; Richard Lempicki; Rose G Mage
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

3.  The gene expression patterns of peripheral blood mononuclear cells in patients with systemic lupus erythematosus.

Authors:  Shouxin Li; Wei Jiang; Rui Huang; Xiaohui Wang; Wen Liu; Shouyin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

Review 4.  Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.

Authors:  Manfred Kunz; Saleh M Ibrahim
Journal:  Mediators Inflamm       Date:  2009-10-26       Impact factor: 4.711

Review 5.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

6.  Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.

Authors:  Dmitry N Grigoryev; Stephen C Mathai; Micah R Fisher; Reda E Girgis; Ari L Zaiman; Traci Housten-Harris; Christopher Cheadle; Li Gao; Laura K Hummers; Hunter C Champion; Joe G N Garcia; Fredrick M Wigley; Rubin M Tuder; Kathleen C Barnes; Paul M Hassoun
Journal:  Transl Res       Date:  2008-02-01       Impact factor: 7.012

7.  Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis.

Authors:  Christopher J Edwards; Jeffrey L Feldman; Jonathan Beech; Kathleen M Shields; Jennifer A Stover; William L Trepicchio; Glenn Larsen; Brian Mj Foxwell; Fionula M Brennan; Marc Feldmann; Debra D Pittman
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

Review 8.  Autoantibodies in systemic lupus erythematosus.

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-12-23       Impact factor: 3.651

Review 9.  Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology.

Authors:  Anatoliy Gladkevich; S Adriaan Nelemans; Henk F Kauffman; Jakob Korf
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

10.  Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.

Authors:  Paul R Dominguez-Gutierrez; Angela Ceribelli; Minoru Satoh; Eric S Sobel; Westley H Reeves; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2014-01-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.